Remedy Entertainment released Control Resonant on PC, PS5, and Xbox Series X/S on September 24, 2026. Following the story of Dylan Faden, the title launched to high critical praise and a 90% positive rating on Steam, effectively clearing the studio’s primary release slot and allowing resources to shift toward its next big-budget endeavors.

Evidence for the Return of Alan Wake
Several indicators point toward the future of the Alan Wake franchise. In September 2026, Remedy Entertainment renewed the “Alan Wake Returns” trademark, a move that often precedes formal announcements or the transition from pre-production to full-scale development.
The financial justification for the franchise has also strengthened. According to the company’s H1 2026 financial report, Alan Wake 2 has surpassed 3 million lifetime sales as of the first half of 2026. This milestone confirms the survival horror sequel’s long-tail commercial success.
Remedy’s Multi-Project Roadmap
The studio is currently managing several high-profile productions. The Max Payne 1 & 2 Remake is currently in full production and expected for a 2027 release. With Control Resonant now in the hands of players, Remedy’s internal capacity has likely opened up for its upcoming projects.
